|
Jun 30
|
Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer's disease trial and interim analysis timeline
|
|
Mar 17
|
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation
|
|
Feb 12
|
Actinogen announces peer-reviewed clinical pharmacology manuscript for Xanamem (emestedastat) published in Clinical Pharmacology in Drug Development journal
|